- Home
- AXDX
as 07-26-2024 4:00pm EST
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.
| Founded: | 1982 | Country: | United States |
| Employees: | N/A | City: | TUCSON |
| Market Cap: | 27.9M | IPO Year: | 1996 |
| Target Price: | $1.00 | AVG Volume (30 days): | 36.5K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.46 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.73 - $7.58 | Next Earning Date: | 08-08-2024 |
| Revenue: | $12,168,000 | Revenue Growth: | -3.47% |
| Revenue Growth (this year): | 4.2% | Revenue Growth (next year): | 17.54% |
Stock Insider Trading Activity of Accelerate Diagnostics Inc. (AXDX)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Mertz Larry Michael | AXDX | Chief Technology Officer | May 20 '24 | Sell | $0.88 | 275 | $242.00 | 81,831 | SEC Form 4 |
| Mertz Larry Michael | AXDX | Chief Technology Officer | May 20 '24 | Sell | $0.88 | 86 | $75.68 | 82,028 | SEC Form 4 |
| Phillips Jack | AXDX | Chief Executive Officer | Apr 17 '24 | Sell | $0.78 | 26,735 | $20,853.30 | 162,919 | SEC Form 4 |
| Phillips Jack | AXDX | Chief Executive Officer | Apr 12 '24 | Sell | $0.86 | 26,545 | $22,828.70 | 129,726 | SEC Form 4 |
| Patience David | AXDX | Chief Financial Officer | Apr 9 '24 | Sell | $0.87 | 13,296 | $11,567.52 | 50,419 | SEC Form 4 |
| Mertz Larry Michael | AXDX | Chief Technology Officer | Apr 9 '24 | Sell | $0.87 | 13,984 | $12,166.08 | 81,106 | SEC Form 4 |
| Mertz Larry Michael | AXDX | Chief Technology Officer | Apr 4 '24 | Sell | $0.88 | 978 | $860.64 | 54,457 | SEC Form 4 |
| Phillips Jack | AXDX | Chief Executive Officer | Apr 4 '24 | Sell | $0.88 | 15,887 | $13,980.56 | 96,343 | SEC Form 4 |
| Patience David | AXDX | Chief Financial Officer | Feb 26 '24 | Sell | $0.96 | 350 | $336.00 | 26,247 | SEC Form 4 |
| Phillips Jack | AXDX | Chief Executive Officer | Feb 1 '24 | Sell | $1.30 | 494 | $642.20 | 76,707 | SEC Form 4 |
| Phillips Jack | AXDX | Chief Executive Officer | Dec 13 '23 | Sell | $4.39 | 739 | $3,244.21 | 59,535 | SEC Form 4 |
| Patience David | AXDX | Chief Financial Officer | Dec 13 '23 | Sell | $4.39 | 97 | $425.83 | 8,931 | SEC Form 4 |
| Patience David | AXDX | Chief Financial Officer | Nov 13 '23 | Sell | $5.57 | 97 | $540.29 | 8,697 | SEC Form 4 |
Latest Accelerate Diagnostics Inc. News
AXDX Breaking Stock News: Dive into AXDX Ticker-Specific Updates for Smart Investing
The Telegraph
2 months ago
Italian energy company targets Britain for fleet of 20 mini-nukes
Simply Wall St.
2 months ago
It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend
Simply Wall St.
2 months ago
Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?
Simply Wall St.
2 months ago
Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks
Motley Fool
2 months ago
4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
Simply Wall St.
2 months ago
Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?
Simply Wall St.
2 months ago
Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)
AFP
2 months ago
Seoul resumes loudspeaker propaganda against North
Compare AXDX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AXDX Accelerate Diagnostics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.